Company intelligence / Profile preview

Vydiant

West Sacramento, California, United Statesvydiant.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vydiant’s OneHealth AI platform integrates over 40 million scientific studies with machine learning and expert curation to deliver actionable insights for healthcare providers, researchers, product developers, and individuals. It maps more than 9,400 evidence-based relationships between lifestyle factors and nearly 3,000 diseases/conditions. The system is used in academic settings such as Concordia University School of Pharmaceutical Sciences. Its mobile app is available free to the public; the company seeks integration with electronic medical records systems like Epic.

Therapeutic areas: PsychiatryCardiovascularInfectious Diseases
Modalities: Non-pharmacological therapy (focus on digital/AI-driven interventions and guidance)
Industry: Digital Health Medical Devices

Partnerships

Concordia University School of Pharmaceutical Sciences uses the software in education/research.

Beyond the preview

Go deeper on Vydiant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vydiant.

Explore the full profile